AMRUTANJAN HEALTH (AMRUTANJAN.NS) Financials
AMRUTANJAN.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 3.6 billion | 930.5 million |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 3.6 billion | 713.2 million |
AMRUTANJAN.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 31.5 million | ? |
| 2023-09-30 | 31.1 million | ? |
| 2023-06-30 | 27.8 million | ? |
| 2023-03-31 | 4.4 million | 4.4 million |
AMRUTANJAN.NS Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 174.5 million |
| 2023-09-30 | 68.5 million |
| 2023-06-30 | 70.1 million |
| 2023-03-31 | 127.0 million |
AMRUTANJAN.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 2.0 billion | - | 6.7 million |
| 2023-06-30 | 1.9 billion | - | - |
| 2023-03-31 | 1.9 billion | 4.0 million | 9.1 million |
AMRUTANJAN.NS Shares Outstanding
AMRUTANJAN.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | 136.3 million | 136.3 million |
| 2023-09-30 | - | - | 170.5 million | 170.5 million |
| 2023-06-30 | - | - | 179.1 million | 65.4 million |
| 2023-03-31 | 89.3 million | 12.0 million | 71.4 million | 71.4 million |
AMRUTANJAN.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 1.2 billion | 565.7 million |
| 2023-09-30 | 993.1 million | 509.1 million |
| 2023-06-30 | 778.6 million | 406.1 million |
| 2023-03-31 | 1.0 billion | 511.0 million |
AMRUTANJAN.NS
Price: ₹711.75
Dividend Yield: 0.01%
Forward Dividend Yield: 0.54%
Payout Ratio: 26.49%
Dividend Per Share: 4.00 INR
Earnings Per Share: 15.13 INR
P/E Ratio: 45.11
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 21.7 billion
Average Dividend Frequency: 3
Years Paying Dividends: 15
DGR3: 30.00%
DGR5: 30.00%
DGR10: 23.43%